Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs

Hepatitis B and C Infection in International Travelers

(2013) Douglas F. Johnson et al.   JOURNAL OF TRAVEL MEDICINE

Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: A retrospective analysis of 49 cases

(2012) Han Hee Ryu et al.   CLINICAL RHEUMATOLOGY

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

(2012) Jing Tan et al.   CLINICAL RHEUMATOLOGY

Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: A case series in Taiwan

(2011) Yung-Tsu CHO et al.   JOURNAL OF DERMATOLOGY

Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts

(2011) Akihiro Tamori et al.   JOURNAL OF GASTROENTEROLOGY

Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy

(2011) Roberto Pérez-Alvarez et al.   MEDICINE

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

(2010) D. Vassilopoulos et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

(2009) Sophia Li et al.   CLINICAL RHEUMATOLOGY

Reactivation of Hepatitis B Viral Infection in Inactive HBsAg Carriers Following Anti-Tumor Necrosis Factor-  Therapy

(2009) S.-J. CHUNG et al.   JOURNAL OF RHEUMATOLOGY

Anti-TNF-  therapy for rheumatoid arthritis among patients with chronic hepatitis B infection

(2009) H. Robinson et al.   RHEUMATOLOGY

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature

(2008) S. Domm et al.   BRITISH JOURNAL OF DERMATOLOGY